Growth Metrics

ClearPoint Neuro (CLPT) Share-based Compensation Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.69%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -4.08%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 12.94%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 26.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 59.09%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 31.63%
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn 16.25%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 16.25%
Dec 31, 2025 16.32%
Sep 30, 2025 6.20%
Jun 30, 2025 26.34%
Mar 31, 2025 26.86%
Dec 31, 2024 10.37%
Sep 30, 2024 20.20%
Jun 30, 2024 9.18%
Mar 31, 2024 15.07%
Dec 31, 2023 31.66%
Sep 30, 2023 34.81%
Jun 30, 2023 86.93%
Mar 31, 2023 45.38%
Dec 31, 2022 26.70%
Sep 30, 2022 100.51%
Jun 30, 2022 256.28%
Mar 31, 2022 180.94%
Dec 31, 2021 182.01%
Sep 30, 2021 100.00%
Jun 30, 2021 2.49%
Mar 31, 2021 40.35%
Dec 31, 2020 47.09%
Sep 30, 2020 33.53%
Jun 30, 2020 18.14%
Mar 31, 2020 49.42%
Dec 31, 2019 -15.18%
Sep 30, 2019 5.39%
Jun 30, 2019 -27.96%
Mar 31, 2019 -38.34%
Sep 30, 2016 -11.45%
Jun 30, 2016 -69.23%
Mar 31, 2016 -49.15%
Sep 30, 2015 40.04%
Jun 30, 2015 320.51%
Mar 31, 2015 110.24%
Dec 31, 2014 -97.28%
Sep 30, 2014 -44.45%
Jun 30, 2014 -43.18%
Mar 31, 2014 -43.56%
Dec 31, 2013 14.25%
Sep 30, 2013 15.09%
Jun 30, 2013 3.32%
Mar 31, 2013 38.55%
Dec 31, 2012 410.28%
Sep 30, 2012 20.83%
Jun 30, 2012 23.55%
Mar 31, 2012 -9.77%